Earnings History Data for Cel-Sci Corporation (CVM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cel-Sci Corporation
CEL-SCI CORP. was formed to acquire and finance research and development of natural human interleukin-2 (``IL-2``) and lymphokine-related products and processes using the Co.'s proprietary cell culture technologies. The Co.'s proprietary product is sometimes referred to as MULTIKINEn, or buffy-coat interleukins, which is a combination, or ``cocktail`` of IL-2 and certain lymphokines and cytokines. MULTIKINE is a trade name of Co. Since its inception the focus of the Co.'s product development efforts has been on conducting clinical trials to test its proprietary technologies.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-08-2024 | ?? | CVM | Cel-Sci Corporation | 62.28 | -0.14 | -0.13 | -0.19 | Cel-Sci GAAP EPS of -$0.42 misses by $0.31 [8/15/2024 8:24 AM] |
1.12 | -0.02 (-1.75%) |
1.11 | -0.03 (-2.63%) |
1.02 - 3.23 | 332,952 | 510,000 | 4,892 | ||
| 16-05-2024 | PM | CVM | CelSci | 75.00 | -0.14 | -0.14 | 0.00 | Cel-Sci GAAP EPS of -$0.28 misses by $0.15 [5/16/2024 9:27 AM] |
1.40 | -0.04 (-3.12%) |
0.0 | 0.0 (0.00%) |
1.04 - 3.23 | 189,897 | 770,000 | 0 | ||
| 22-12-2023 | PM | CVM | CelSci | 136.00 | -0.16 | -0.16 | 0.00 | 2.73 | 0.06 (2.25%) |
2.78 | 0.11 (4.12%) |
1.04 - 3.33 | 241,467 | 350,000 | 2,434 | |||
|
|
||||||||||||||||||
| 11-08-2023 | PM | CVM | CelSci | 68.00 | -0.19 | -0.17 | 0.00 | Cel-Sci GAAP EPS of -$0.57 [8/11/2023 8:47 AM] |
1.24 | -0.18 (-12.68%) |
1.38 | -0.04 (-2.80%) |
1.22 - 5.42 | 440,264 | 400,000 | 6,079 | ||
| 12-05-2023 | AH | CVM | Cel-Sci Corporation | 118.60 | -0.19 | 0.00 | -0.23 | Cel-Sci GAAP EPS of -$0.19 misses by $0.02 [5/12/2023 4:58 PM] |
2.60 | 0.20 (8.33%) |
2.60 | 0.20 (8.33%) |
1.86 - 5.42 | 94,404 | 160,000 | 4,883 | ||
| 16-05-2022 | PM | CVM | CelSci | 122.00 | -0.23 | -0.16 | 0.00 | Cel-Sci GAAP EPS of -$0.43 misses by $0.27 [5/16/2022 9:00 AM] |
2.95 | 0.11 (3.87%) |
0.0 | 0.0 (0.00%) |
2.49 - 27.28 | 400,627 | 710,000 | 0 | ||
| 14-02-2022 | PM | CVM | Cel-Sci Corporation | 243.47 | -0.20 | 0.00 | -0.21 | Cel-Sci GAAP EPS of -$0.20 [2/14/2022 9:05 AM] |
5.81 | 0.40 (7.39%) |
5.41 | 0.0 (0.00%) |
5.11 - 27.86 | 491,539 | 650,000 | 2,300 | ||
| 22-12-2021 | PM | CVM | CelSci | 344.00 | -0.19 | -0.10 | 0.00 | Cel-Sci EPS misses by $0.70 [12/22/2021 9:17 AM] |
8.06 | 0.23 (2.94%) |
0.0 | 0.0 (0.00%) |
7.08 - 40.91 | 706,734 | 1,460,000 | 0 | ||
| 16-08-2021 | PM | CVM | Celsci Corporation | 402.00 | -0.25 | -0.13 | 0.00 | Cel-Sci reports Q3 results [8/16/2021 9:08 AM] |
9.09 | 0.06 (0.66%) |
0.0 | 0.0 (0.00%) |
7.08 - 40.91 | 633,612 | 890,000 | 0 | ||
| 18-05-2021 | PM | CVM | Cel-Sci Corporation | 835.31 | -0.20 | -0.19 | -0.17 | Cel-Sci reports FQ2 results [5/18/2021 9:06 AM] |
19.56 | 0.67 (3.55%) |
19.19 | 0.30 (1.59%) |
10.76 - 40.91 | 646,889 | 640,000 | 10,316 | ||
| 16-02-2021 | PM | CVM | Cel-Sci Corporation | 917.04 | -0.21 | 0.00 | -0.16 | Cel-Sci reports FQ1 results [2/16/2021 9:10 AM] |
23.55 | 0.49 (2.12%) |
24.00 | 0.45 (1.91%) |
6.35 - 40.91 | 585,924 | 1,106,425 | 7,134 | ||
| 11-08-2020 | PM | CVM | Cel-Sci Corporation | 452.74 | -0.27 | -0.15 | -0.37 | Cel-Sci EPS misses by $0.12, beats on revenue [8/11/2020 8:38 AM] |
12.71 | 0.27 (2.17%) |
12.42 | -0.02 (-0.16%) |
6.00 - 18.00 | 224,366 | 386,005 | 2,628 | ||
|
|
||||||||||||||||||